These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Defining AML and MDS second cancer risk dynamics after diagnoses of first cancers treated or not with radiation. Radivoyevitch T, Sachs RK, Gale RP, Molenaar RJ, Brenner DJ, Hill BT, Kalaycio ME, Carraway HE, Mukherjee S, Sekeres MA, Maciejewski JP. Leukemia; 2016 Feb; 30(2):285-94. PubMed ID: 26460209 [Abstract] [Full Text] [Related]
24. Leukemia incidence following primary breast carcinoma treatment. Kaplan HG, Malmgren JA, Atwood M. Cancer; 2004 Oct 01; 101(7):1529-36. PubMed ID: 15378478 [Abstract] [Full Text] [Related]
25. Second lymphomas and other malignant neoplasms in patients with mycosis fungoides and Sezary syndrome: evidence from population-based and clinical cohorts. Huang KP, Weinstock MA, Clarke CA, McMillan A, Hoppe RT, Kim YH. Arch Dermatol; 2007 Jan 01; 143(1):45-50. PubMed ID: 17224541 [Abstract] [Full Text] [Related]
27. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy. Hershman D, Neugut AI, Jacobson JS, Wang J, Tsai WY, McBride R, Bennett CL, Grann VR. J Natl Cancer Inst; 2007 Feb 07; 99(3):196-205. PubMed ID: 17284714 [Abstract] [Full Text] [Related]
28. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group. Takenaka K, Nishida T, Asano-Mori Y, Oshima K, Ohashi K, Mori T, Kanamori H, Miyamura K, Kato C, Kobayashi N, Uchida N, Nakamae H, Ichinohe T, Morishima Y, Suzuki R, Yamaguchi T, Fukuda T. Biol Blood Marrow Transplant; 2015 Nov 07; 21(11):2008-16. PubMed ID: 26211985 [Abstract] [Full Text] [Related]
33. A review of therapy-related myelodysplastic syndromes and acute myeloid leukaemia (t-MDS/AML) in Irish patients: a single centre experience. Maung SW, Burke C, Hayde J, Walshe J, McDermott R, Desmond R, McHugh J, Enright H. Hematology; 2017 Jul 07; 22(6):341-346. PubMed ID: 28196450 [Abstract] [Full Text] [Related]
34. Are chronic myeloid leukemia patients more at risk for second malignancies? A population-based study. Rebora P, Czene K, Antolini L, Gambacorti Passerini C, Reilly M, Valsecchi MG. Am J Epidemiol; 2010 Nov 01; 172(9):1028-33. PubMed ID: 20861143 [Abstract] [Full Text] [Related]
35. Risk of subsequent primary leukaemias among 69,460 five-year survivors of childhood cancer diagnosed from 1940 to 2008 in Europe: A cohort study within PanCareSurFup. Allodji RS, Hawkins MM, Bright CJ, Fidler-Benaoudia MM, Winter DL, Alessi D, Fresneau B, Journy N, Morsellino V, Bárdi E, Bautz A, Byrne J, Feijen ELA, Teepen JC, Vu-Bezin G, Rubino C, Garwicz S, Grabow D, Gudmundsdottir T, Guha J, Hau EM, Jankovic M, Kaatsch P, Kaiser M, Linge H, Muraca M, Llanas D, Veres C, Øfstaas H, Diallo I, Mansouri I, Ronckers CM, Skinner R, Terenziani M, Wesenberg F, Wiebe T, Sacerdote C, Jakab Z, Haupt R, Lähteenmäki P, Zaletel LZ, Kuehni CE, Winther JF, Michel G, Kremer LCM, Hjorth L, Haddy N, de Vathaire F, Reulen RC. Eur J Cancer; 2019 Aug 01; 117():71-83. PubMed ID: 31260818 [Abstract] [Full Text] [Related]
36. Risk of second primary breast cancer among cancer survivors: Implications for prevention and screening practice. Cheng Y, Huang Z, Liao Q, Yu X, Jiang H, He Y, Yao S, Nie S, Liu L. PLoS One; 2020 Aug 01; 15(6):e0232800. PubMed ID: 32497148 [Abstract] [Full Text] [Related]